BIOLOGICAL MATERIALS LICENSE AGREEMENTBiological Materials License Agreement • May 5th, 2020 • District of Columbia
This Agreement is entered into between the U.S. Government, as represented by the U.S. Department of Agriculture, Agricultural Research Service (hereinafter referred to as “USDA”) and (company name), a (state) corporation having offices at (street address, city, and state) (hereinafter referred to as “COMPANY”).
BIOLOGICAL MATERIALS LICENSE AGREEMENTBiological Materials License Agreement • May 5th, 2020 • District of Columbia
This Agreement is entered into between the National Center for , Centers for Disease Control and Prevention (“CDC”), at 1600 Clifton Rd., N.E., Atlanta, Georgia, 30333, U.S.A. and ("LICENSEE"), having an office at .
THE NATIONAL INSTITUTES OF HEALTH BIOLOGICAL MATERIALS LICENSE AGREEMENTBiological Materials License Agreement • May 5th, 2020 • District of Columbia
This Agreement is entered into between the National Institutes of Health (“NIH”) within the Department of Health and Human Services (“HHS”) through the Office of Technology Transfer, NIH, having an address at 6011 Executive Boulevard, Suite 325, Rockville, Maryland 20852‑3804, U.S.A. and ____________________ (the “Licensee”), a corporation of ____________________, having an office at ________________________________________.
BIOLOGICAL MATERIALS LICENSE AGREEMENTBiological Materials License Agreement • July 6th, 2020 • District of Columbia
This Agreement is entered into between the U.S. Government, as represented by the U.S. Department of Agriculture, Agricultural Research Service (hereinafter referred to as “USDA”) and (company name), a (state) corporation having offices at (street address, city, and state) (hereinafter referred to as “COMPANY”).
